SCHEMBL24924036

SCHEMBL24924036

O=C1CC2C=C(c3c[nH]cn3)CC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5939457 0.76 CDK9 (0.33)
SCHEMBL5939462 0.76 CDK9 (0.33)
Hydrochloric Acid SCHEMBL5938901 0.75 CDK9 (0.33)
Hydrochloric Acid SCHEMBL5938910 0.75 CDK9 (0.33)
SCHEMBL7607611 0.65 CFTR (0.36)
SCHEMBL24923905 0.65 BRD4 (0.36)
SCHEMBL7668468 0.64
SCHEMBL7185897 0.62 SLC6A4 (0.48)
SCHEMBL6843937 0.62 SLC6A4 (0.48)
SCHEMBL23716669 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030869-B2 5-membered heteroaryl carboxamide compounds for treatment of HBV ASSEMBLY BIOSCIENCES, INC. (US) 2024-07-09 US disclosed
US-12030869-B2 5-membered heteroaryl carboxamide compounds for treatment of HBV ASSEMBLY BIOSCIENCES, INC. (US) 2024-07-09 US disclosed
US-11560370-B1 5-membered heteroaryl carboxamide compounds for treatment of HBV ASSEMBLY BIOSCIENCES, INC. (US) 2023-01-24 US disclosed
CN-113195055-A 5-membered heteroaryl carboxamide compounds for HBV therapy 组装生物科学股份有限公司 2021-07-30 CN disclosed